Subscribe To
Japanese yen eyes new lows as markets speculate on boj action. intervention ahead?
The Japanese Yen is facing scrutiny to start the week with USD/JPY edging toward prior peaks on growing...
October 23, 2023, 4:30 am
Toyota to resume operations at remaining halted plants from tuesday
Toyota Motor will gradually restart operations from Tuesday morning at the remaining lines of group plants that had been halted due to an accident at ...
October 23, 2023, 4:10 am
Merck discontinues some cancer drug development with china's sichuan kelun
Chinese drugmaker Sichuan Kelun Pharmaceutical Co said on Monday that Merck & Co Inc was abandoning the joint development of two candidate cancer drug...
October 23, 2023, 3:47 am
Eur/usd could recover, bitcoin price clears $30k
EUR/USD is attempting a recovery wave above the 1.0550 resistance. Bitcoin price started a steady incre...
October 23, 2023, 3:29 am
Eur/usd could recover, bitcoin price clears $30k
Key Highlights EUR/USD is attempting a recovery wave above the 1.0550 resistance. A key contracting triangle is forming with resistance near 1.0600 on...
October 23, 2023, 3:28 am
Tirupati graphite expects price rise boost as china restricts exports
Tirupati Graphite said it expected prices to rise following China's introduction of export controls from the s...
October 23, 2023, 2:33 am
Crude oil correction in play; natural gas’ rebound may not be over
Crude oil’s downward correction that started a few weeks ago may not be over just yet. Natural gas ha...
October 23, 2023, 2:30 am
Japan launches antimonopoly probe into google's search dominance
Japan's competition watchdog on Monday said it would start investigating Google's possible breach of an...
October 23, 2023, 2:20 am
Gold price slips after stellar rally despite lofty treasury yields. higher xau/usd?
The gold price pulled back to start the week after notching a five-week peak last Friday. Higher Treasu...
October 23, 2023, 12:30 am
Oil prices ease as aid convoys arrive in embattled gaza strip
Oil prices eased on Monday as aid convoys started to arrive in the Gaza Strip over the weekend amid dip...
October 22, 2023, 8:44 pm
Samsung sdi says to supply ev batteries to hyundai motor starting 2026
South Korea's Samsung SDI said on Monday it will supply Hyundai Motor with electric vehicle batteries for seven years...
October 22, 2023, 7:01 pm
Forex and cryptocurrencies forecast
EUR/USD: No Interest Rate Hikes from the Fed and ECB in the Near Future? starting from the last days of...
October 22, 2023, 12:05 pm
Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me
42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...
October 22, 2023, 10:01 am
Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me
42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...
October 22, 2023, 10:01 am
Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me
42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...
October 22, 2023, 10:01 am
Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me
42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...
October 22, 2023, 10:01 am
Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me
42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...
October 22, 2023, 10:01 am
Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me
42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...
October 22, 2023, 10:01 am
Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me
42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...
October 22, 2023, 10:01 am
Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me
42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...
October 22, 2023, 10:01 am